Tenon Medical (NASDAQ:TNON – Get Free Report) and Calmare Therapeutics (OTCMKTS:CTTC – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.
Insider and Institutional Ownership
22.7% of Tenon Medical shares are held by institutional investors. 4.7% of Tenon Medical shares are held by insiders. Comparatively, 17.5% of Calmare Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Tenon Medical and Calmare Therapeutics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Tenon Medical | -413.88% | -1,785.88% | -164.26% |
Calmare Therapeutics | N/A | N/A | N/A |
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Tenon Medical | 0 | 0 | 2 | 0 | 3.00 |
Calmare Therapeutics | 0 | 0 | 0 | 0 | 0.00 |
Tenon Medical presently has a consensus target price of $5.50, suggesting a potential upside of 180.61%. Given Tenon Medical’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Tenon Medical is more favorable than Calmare Therapeutics.
Earnings and Valuation
This table compares Tenon Medical and Calmare Therapeutics”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Tenon Medical | $2.93 million | 2.10 | -$15.58 million | ($27.23) | -0.07 |
Calmare Therapeutics | N/A | N/A | N/A | N/A | N/A |
Calmare Therapeutics has lower revenue, but higher earnings than Tenon Medical.
Summary
Tenon Medical beats Calmare Therapeutics on 5 of the 9 factors compared between the two stocks.
About Tenon Medical
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
About Calmare Therapeutics
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.